US Pharma MarketingAmidst vaccine confusion, we must follow the evidence to protect against meningococcal disease
Amidst vaccine confusion, we must follow the evidence to protect against meningococcal disease is a pharma and life sciences industry update from Fierce Healthcare. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Routine vaccination against IMD is essential to sustaining immunity during the years when young people are at greatest risk.
Source: Fierce Healthcare